Trial Outcomes & Findings for Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study) (NCT NCT00632021)

NCT ID: NCT00632021

Last Updated: 2017-09-01

Results Overview

Number of clinically important medication errors per patient

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

862 participants

Primary outcome timeframe

Measured at Day 30

Results posted on

2017-09-01

Participant Flow

Adults admitted to Vanderbilt University Hospital or Brigham and Women's Hospital for acute coronary syndromes or acute decompensated heart failure were enrolled between May 2008 and September 2009. We enrolled and randomized 862 patients. Eleven patients withdrew consent or died in the hospital, leaving 851 patients in the analysis.

This was a randomized, controlled trial with concealed allocation and blinded outcome assessors. We enrolled and randomized 862 patients (430 intervention and 432 usual care). Eleven patients (7 intervention and 4 usual care) withdrew consent or died in the hospital, leaving 851 patients in the intention-to-treat analysis.

Participant milestones

Participant milestones
Measure
Control (Usual Care)
Control (usual care) arm
Intervention
Intervention arm
Overall Study
STARTED
432
430
Overall Study
COMPLETED
428
423
Overall Study
NOT COMPLETED
4
7

Reasons for withdrawal

Reasons for withdrawal
Measure
Control (Usual Care)
Control (usual care) arm
Intervention
Intervention arm
Overall Study
Withdrawal/death
4
7

Baseline Characteristics

Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control (Usual Care)
n=428 Participants
Control (usual care) arm
Intervention
n=423 Participants
Intervention arm
Total
n=851 Participants
Total of all reporting groups
Age, Continuous
59 years
STANDARD_DEVIATION 14 • n=5 Participants
61 years
STANDARD_DEVIATION 14 • n=7 Participants
60 years
STANDARD_DEVIATION 14 • n=5 Participants
Sex: Female, Male
Female
179 Participants
n=5 Participants
173 Participants
n=7 Participants
352 Participants
n=5 Participants
Sex: Female, Male
Male
249 Participants
n=5 Participants
250 Participants
n=7 Participants
499 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
Race (NIH/OMB)
Asian
4 Participants
n=5 Participants
3 Participants
n=7 Participants
7 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
71 Participants
n=5 Participants
77 Participants
n=7 Participants
148 Participants
n=5 Participants
Race (NIH/OMB)
White
335 Participants
n=5 Participants
319 Participants
n=7 Participants
654 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
16 Participants
n=5 Participants
21 Participants
n=7 Participants
37 Participants
n=5 Participants
Region of Enrollment
United States
428 Number of participants
n=5 Participants
423 Number of participants
n=7 Participants
851 Number of participants
n=5 Participants
Study Site
Vanderbilt University Hospital
200 Participants
n=5 Participants
197 Participants
n=7 Participants
397 Participants
n=5 Participants
Study Site
Brigham and Women's Hospital
228 Participants
n=5 Participants
226 Participants
n=7 Participants
454 Participants
n=5 Participants
Health literacy (sTOFHLA score)
Inadequate
39 Participants
n=5 Participants
47 Participants
n=7 Participants
86 Participants
n=5 Participants
Health literacy (sTOFHLA score)
Marginal
38 Participants
n=5 Participants
36 Participants
n=7 Participants
74 Participants
n=5 Participants
Health literacy (sTOFHLA score)
Adequate
340 Participants
n=5 Participants
331 Participants
n=7 Participants
671 Participants
n=5 Participants
Health literacy (sTOFHLA score)
Missing
11 Participants
n=5 Participants
9 Participants
n=7 Participants
20 Participants
n=5 Participants
Language
English
425 Participants
n=5 Participants
414 Participants
n=7 Participants
839 Participants
n=5 Participants
Language
Spanish
3 Participants
n=5 Participants
9 Participants
n=7 Participants
12 Participants
n=5 Participants
Education
14 years
n=5 Participants
14 years
n=7 Participants
14 years
n=5 Participants
Income
<10K
17 Participants
n=5 Participants
20 Participants
n=7 Participants
37 Participants
n=5 Participants
Income
10K to <15K
24 Participants
n=5 Participants
21 Participants
n=7 Participants
45 Participants
n=5 Participants
Income
15K to <20K
19 Participants
n=5 Participants
23 Participants
n=7 Participants
42 Participants
n=5 Participants
Income
20K to <25K
47 Participants
n=5 Participants
56 Participants
n=7 Participants
103 Participants
n=5 Participants
Income
25K to <35K
49 Participants
n=5 Participants
49 Participants
n=7 Participants
98 Participants
n=5 Participants
Income
35K to <50K
56 Participants
n=5 Participants
54 Participants
n=7 Participants
110 Participants
n=5 Participants
Income
50K to <75K
60 Participants
n=5 Participants
58 Participants
n=7 Participants
118 Participants
n=5 Participants
Income
75K+
119 Participants
n=5 Participants
105 Participants
n=7 Participants
224 Participants
n=5 Participants
Income
Missing
37 Participants
n=5 Participants
37 Participants
n=7 Participants
74 Participants
n=5 Participants
Cognition (Mini cog score)
Impaired
46 Participants
n=5 Participants
52 Participants
n=7 Participants
98 Participants
n=5 Participants
Cognition (Mini cog score)
Not impaired
380 Participants
n=5 Participants
371 Participants
n=7 Participants
751 Participants
n=5 Participants
Cognition (Mini cog score)
Missing
2 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants
Has primary care provider
Yes
392 Participants
n=5 Participants
386 Participants
n=7 Participants
778 Participants
n=5 Participants
Has primary care provider
No
36 Participants
n=5 Participants
37 Participants
n=7 Participants
73 Participants
n=5 Participants
Number of pre-admission medications
7 Medications
n=5 Participants
8 Medications
n=7 Participants
8 Medications
n=5 Participants
Comorbidities
Diabetes
195 participants
n=5 Participants
140 participants
n=7 Participants
335 participants
n=5 Participants
Comorbidities
Hypertension
296 participants
n=5 Participants
306 participants
n=7 Participants
602 participants
n=5 Participants
Comorbidities
Hypercholesterolemia
236 participants
n=5 Participants
234 participants
n=7 Participants
470 participants
n=5 Participants
Comorbidities
Coronary artery disease
211 participants
n=5 Participants
225 participants
n=7 Participants
436 participants
n=5 Participants
Comorbidities
Prior myocardial infarction
73 participants
n=5 Participants
100 participants
n=7 Participants
173 participants
n=5 Participants
Comorbidities
Prior stroke or cerebrovascular event
41 participants
n=5 Participants
30 participants
n=7 Participants
71 participants
n=5 Participants
Comorbidities
Prior coronary revascularization procedure
195 participants
n=5 Participants
203 participants
n=7 Participants
398 participants
n=5 Participants
Marital status
Married/cohabitating
256 Participants
n=5 Participants
226 Participants
n=7 Participants
482 Participants
n=5 Participants
Marital status
Single/living alone
172 Participants
n=5 Participants
197 Participants
n=7 Participants
369 Participants
n=5 Participants
Insurance status
Medicare
162 Participants
n=5 Participants
177 Participants
n=7 Participants
339 Participants
n=5 Participants
Insurance status
Medicaid
37 Participants
n=5 Participants
44 Participants
n=7 Participants
81 Participants
n=5 Participants
Insurance status
Commercial
203 Participants
n=5 Participants
167 Participants
n=7 Participants
370 Participants
n=5 Participants
Insurance status
Self-pay/other
26 Participants
n=5 Participants
35 Participants
n=7 Participants
61 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Measured at Day 30

Number of clinically important medication errors per patient

Outcome measures

Outcome measures
Measure
Control
n=428 Participants
Control (usual care) arm
Intervention
n=423 Participants
Intervention arm
Number of Serious Medication Errors as Determined by Interview and Medical Chart Review
0.95 serious medication errors
Standard Deviation 1.36
0.87 serious medication errors
Standard Deviation 1.18

SECONDARY outcome

Timeframe: Measured at Day 30

Unplanned hospitalizations and Emergency Department visits

Outcome measures

Outcome measures
Measure
Control
n=428 Participants
Control (usual care) arm
Intervention
n=423 Participants
Intervention arm
Number of Participants With Unplanned Hospitalizations and Emergency Department Visits
Hospital readmission
66 Participants
61 Participants
Number of Participants With Unplanned Hospitalizations and Emergency Department Visits
No readmission
362 Participants
362 Participants

Adverse Events

Control (Usual Care)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Research Coordinator

Vanderbilt University Medical Center

Phone: 6159364819

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place